Global, regional, and national cancer incidence and death for 29 cancer groups in 2019 and trends analysis of the global cancer burden, 1990–2019

Abstract Background and aims Cancer will soon become the leading cause of death in every country in the twenty-first century. This study aimed to analyze the mortality and morbidity of 29 types of cancer in 204 countries or regions from 1990 to 2019 to guide global cancer prevention and control. Met...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Longfei Lin, Zhiyong Li, Lei Yan, Yuling Liu, Hongjun Yang, Hui Li
Formato: article
Lenguaje:EN
Publicado: BMC 2021
Materias:
Acceso en línea:https://doaj.org/article/fa3bfe9f05cd4c03b680cdc4c2eded94
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:fa3bfe9f05cd4c03b680cdc4c2eded94
record_format dspace
spelling oai:doaj.org-article:fa3bfe9f05cd4c03b680cdc4c2eded942021-11-28T12:03:23ZGlobal, regional, and national cancer incidence and death for 29 cancer groups in 2019 and trends analysis of the global cancer burden, 1990–201910.1186/s13045-021-01213-z1756-8722https://doaj.org/article/fa3bfe9f05cd4c03b680cdc4c2eded942021-11-01T00:00:00Zhttps://doi.org/10.1186/s13045-021-01213-zhttps://doaj.org/toc/1756-8722Abstract Background and aims Cancer will soon become the leading cause of death in every country in the twenty-first century. This study aimed to analyze the mortality and morbidity of 29 types of cancer in 204 countries or regions from 1990 to 2019 to guide global cancer prevention and control. Methods Detailed information for 29 cancer groups was collected from the Global Burden of Disease Study in 2019. The age-standardized incidence rate (ASIR) and age-standardized death rate (ASDR) of the 29 cancer groups were calculated based on sex, age, region, and country. In addition, separate analyses were performed for major cancer types. Results In 2019, more than 10 million people died from cancer, which was approximately twice the number in 1990. Tracheal, bronchus, and lung (TBL) cancers collectively showed the highest death rate, and the ASDR of pancreatic cancer increased by 24%, which was cancer with the highest case fatality rate (CFR). The global cancer ASIR showed an increasing trend, with testicular cancer, thyroid cancer, and malignant skin melanoma showing a significant increase. The ASDR and ASIR of cancer in males were about 1.5 times higher than that in females. Individuals over 50 years had the highest risk of developing cancer, with incidences and deaths in this age group accounting for more than 85% of cancers in all age groups. Asia has the heaviest cancer burden due to its high population density, with esophageal cancer in this region accounting for 53% of the total fatalities related to this type of cancer in the world. In addition, the mortality and morbidity of most cancers increased with the increase in the development or socio-demographic index (SDI) in the SDI regions based on the World Bank's Human Development Index (HDI), with cancer characteristics varying in the different countries globally. Conclusions The global cancer burden continues to increase, with substantial mortality and morbidity differences among the different regions, ages, countries, gender, and cancer types. Effective and locally tailored cancer prevention and control measures are essential in reducing the global cancer burden in the future.Longfei LinZhiyong LiLei YanYuling LiuHongjun YangHui LiBMCarticleGlobal burden of diseaseCancerIncidenceDeathDiseases of the blood and blood-forming organsRC633-647.5Neoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENJournal of Hematology & Oncology, Vol 14, Iss 1, Pp 1-24 (2021)
institution DOAJ
collection DOAJ
language EN
topic Global burden of disease
Cancer
Incidence
Death
Diseases of the blood and blood-forming organs
RC633-647.5
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
spellingShingle Global burden of disease
Cancer
Incidence
Death
Diseases of the blood and blood-forming organs
RC633-647.5
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Longfei Lin
Zhiyong Li
Lei Yan
Yuling Liu
Hongjun Yang
Hui Li
Global, regional, and national cancer incidence and death for 29 cancer groups in 2019 and trends analysis of the global cancer burden, 1990–2019
description Abstract Background and aims Cancer will soon become the leading cause of death in every country in the twenty-first century. This study aimed to analyze the mortality and morbidity of 29 types of cancer in 204 countries or regions from 1990 to 2019 to guide global cancer prevention and control. Methods Detailed information for 29 cancer groups was collected from the Global Burden of Disease Study in 2019. The age-standardized incidence rate (ASIR) and age-standardized death rate (ASDR) of the 29 cancer groups were calculated based on sex, age, region, and country. In addition, separate analyses were performed for major cancer types. Results In 2019, more than 10 million people died from cancer, which was approximately twice the number in 1990. Tracheal, bronchus, and lung (TBL) cancers collectively showed the highest death rate, and the ASDR of pancreatic cancer increased by 24%, which was cancer with the highest case fatality rate (CFR). The global cancer ASIR showed an increasing trend, with testicular cancer, thyroid cancer, and malignant skin melanoma showing a significant increase. The ASDR and ASIR of cancer in males were about 1.5 times higher than that in females. Individuals over 50 years had the highest risk of developing cancer, with incidences and deaths in this age group accounting for more than 85% of cancers in all age groups. Asia has the heaviest cancer burden due to its high population density, with esophageal cancer in this region accounting for 53% of the total fatalities related to this type of cancer in the world. In addition, the mortality and morbidity of most cancers increased with the increase in the development or socio-demographic index (SDI) in the SDI regions based on the World Bank's Human Development Index (HDI), with cancer characteristics varying in the different countries globally. Conclusions The global cancer burden continues to increase, with substantial mortality and morbidity differences among the different regions, ages, countries, gender, and cancer types. Effective and locally tailored cancer prevention and control measures are essential in reducing the global cancer burden in the future.
format article
author Longfei Lin
Zhiyong Li
Lei Yan
Yuling Liu
Hongjun Yang
Hui Li
author_facet Longfei Lin
Zhiyong Li
Lei Yan
Yuling Liu
Hongjun Yang
Hui Li
author_sort Longfei Lin
title Global, regional, and national cancer incidence and death for 29 cancer groups in 2019 and trends analysis of the global cancer burden, 1990–2019
title_short Global, regional, and national cancer incidence and death for 29 cancer groups in 2019 and trends analysis of the global cancer burden, 1990–2019
title_full Global, regional, and national cancer incidence and death for 29 cancer groups in 2019 and trends analysis of the global cancer burden, 1990–2019
title_fullStr Global, regional, and national cancer incidence and death for 29 cancer groups in 2019 and trends analysis of the global cancer burden, 1990–2019
title_full_unstemmed Global, regional, and national cancer incidence and death for 29 cancer groups in 2019 and trends analysis of the global cancer burden, 1990–2019
title_sort global, regional, and national cancer incidence and death for 29 cancer groups in 2019 and trends analysis of the global cancer burden, 1990–2019
publisher BMC
publishDate 2021
url https://doaj.org/article/fa3bfe9f05cd4c03b680cdc4c2eded94
work_keys_str_mv AT longfeilin globalregionalandnationalcancerincidenceanddeathfor29cancergroupsin2019andtrendsanalysisoftheglobalcancerburden19902019
AT zhiyongli globalregionalandnationalcancerincidenceanddeathfor29cancergroupsin2019andtrendsanalysisoftheglobalcancerburden19902019
AT leiyan globalregionalandnationalcancerincidenceanddeathfor29cancergroupsin2019andtrendsanalysisoftheglobalcancerburden19902019
AT yulingliu globalregionalandnationalcancerincidenceanddeathfor29cancergroupsin2019andtrendsanalysisoftheglobalcancerburden19902019
AT hongjunyang globalregionalandnationalcancerincidenceanddeathfor29cancergroupsin2019andtrendsanalysisoftheglobalcancerburden19902019
AT huili globalregionalandnationalcancerincidenceanddeathfor29cancergroupsin2019andtrendsanalysisoftheglobalcancerburden19902019
_version_ 1718408296513142784